The Journal of Clinical Endocrinology & Metabolism · 2013 · 193 citations · 23 references
Life SciencesNutritionNutritional SciencesBioavailabilityClinical NutritionHuman NutritionCholesterol MetabolismFat-soluble VitaminsOral ProbioticsProbioticsVitamin DVitamin SupplementationCholesterol-lowering EffectsFat-soluble Vitamin SupplementationLactobacillus-based Oral ProbioticsLow-density Lipoprotein Cholesterol LoweringLow-density Lipoprotein Cholesterol ReductionOral SupplementationProbiotic Effects On AbsorptionProbiotic Supplements
CONTEXT: Low serum 25-hydroxyvitamin D is a risk factor for osteoporosis, cardiovascular disease, diabetes, and cancer. Disruption of noncholesterol sterol absorption due to cholesterol-lowering therapies may result in reduced fat-soluble vitamin absorption. OBJECTIVE: We have previously reported on the cholesterol-lowering efficacy and reduced sterol absorption of probiotic bile salt hydrolase active Lactobacillus reuteri NCIMB 30242; however, the effects on fat-soluble vitamins was previously unknown and the objective of the present study. DESIGN, SETTINGS, PATIENTS, AND INTERVENTION: The study was double-blind, placebo-controlled, randomized, parallel-arm, multicenter lasting 13 weeks. A total of 127 otherwise healthy hypercholesterolemic adults with low-density lipoprotein-cholesterol >3.4 mmol/L, triglycerides <4.0 mmol/L, and body mass index of 22 to 32 kg/m² were included. Subjects were recruited from 6 private practices in Prague, Czech Republic, and randomized to consume L. reuteri NCIMB 30242 or placebo capsules over a 9-week intervention period. OUTCOME MEASURES: The primary outcome measure was the change in serum low-density lipoprotein-cholesterol over the 9-week intervention. Analysis of fat-soluble vitamins at weeks 0 and 9 were performed post hoc. RESULTS: There were no significant differences between L. reuteri NCIMB 30242 and placebo capsule groups in serum vitamin A, vitamin E, or β-carotene or dietary intake over the intervention period (P > .05). L. reuteri NCIMB 30242 increased serum 25-hydroxyvitamin D by 14.9 nmol/L, or 25.5%, over the intervention period, which was a significant mean change relative to placebo of 17.1 nmol/L, or 22.4%, respectively (P = .003). CONCLUSIONS: To our knowledge, this is the first report of increased circulating 25-hydroxyvitamin D in response to oral probiotic supplementation.
23
Vitamin D Deficiency and Risk of Cardiovascular Disease
Thomas J. Wang, Michael J. Pencina, Sarah L. Booth et al. · Circulation · 2008 · 2.4K citations · Full text
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
Omry Koren, Julia K. Goodrich, Tyler C. Cullender et al. · Cell · 2012 · 2.2K citations · Full text
Stefanie Schulze Schleithoff, Armin Zittermann, Gero Tenderich et al. · American Journal of Clinical Nutrition · 2006 · 927 citations